Tolerability and first hints for potential efficacy of motor-cognitive training under inspiratory hypoxia in health and neuropsychiatric disorders: A translational viewpoint.

brain cognition erythropoietin functional hypoxia high-parameter flow cytometry immune cells oxygen saturation physical fitness plasticity

Journal

Neuroprotection
ISSN: 2770-730X
Titre abrégé: Neuroprotection
Pays: England
ID NLM: 9918452086806676

Informations de publication

Date de publication:
01 Sep 2024
Historique:
medline: 15 10 2024
pubmed: 15 10 2024
entrez: 15 10 2024
Statut: ppublish

Résumé

Hypoxia is more and more perceived as pivotal physiological driving force, allowing cells in the brain and elsewhere to acclimate to lowered oxygen (O

Identifiants

DOI: 10.1002/nep3.47 PMID: 39404697 PMC: PMC7616549
pubmed: 39404697
doi: 10.1002/nep3.47
pmc: PMC7616549
doi:

Types de publication

Journal Article

Langues

eng

Pagination

228-242

Déclaration de conflit d'intérêts

Conflict of Interest Statement The authors declare no conflict of interest.

Auteurs

Svea-Solveig Mennen (SS)

Clinical Neuroscience, Max Planck Institute for Multidisciplinary Sciences, City Campus, Göttingen, Germany.
Georg-August-University, Göttingen, Germany.

Maren Franta (M)

Clinical Neuroscience, Max Planck Institute for Multidisciplinary Sciences, City Campus, Göttingen, Germany.
Georg-August-University, Göttingen, Germany.

Martin Begemann (M)

Clinical Neuroscience, Max Planck Institute for Multidisciplinary Sciences, City Campus, Göttingen, Germany.
Georg-August-University, Göttingen, Germany.

Justus B H Wilke (JBH)

Clinical Neuroscience, Max Planck Institute for Multidisciplinary Sciences, City Campus, Göttingen, Germany.

Roman Schröder (R)

Clinical Neuroscience, Max Planck Institute for Multidisciplinary Sciences, City Campus, Göttingen, Germany.
Georg-August-University, Göttingen, Germany.

Umer Javed Butt (UJ)

Clinical Neuroscience, Max Planck Institute for Multidisciplinary Sciences, City Campus, Göttingen, Germany.

Jonathan-Alexis Cortés-Silva (JA)

Clinical Neuroscience, Max Planck Institute for Multidisciplinary Sciences, City Campus, Göttingen, Germany.

Umut Çakır (U)

Clinical Neuroscience, Max Planck Institute for Multidisciplinary Sciences, City Campus, Göttingen, Germany.
Georg-August-University, Göttingen, Germany.

Marie Güra (M)

Clinical Neuroscience, Max Planck Institute for Multidisciplinary Sciences, City Campus, Göttingen, Germany.
Georg-August-University, Göttingen, Germany.

Markus de Marées (M)

Department of Sports Medicine, Ruhr University, Bochum, Germany.

Vinicius Daguano Gastaldi (VD)

Clinical Neuroscience, Max Planck Institute for Multidisciplinary Sciences, City Campus, Göttingen, Germany.
Georg-August-University, Göttingen, Germany.

Johannes Burtscher (J)

Institute of Sports Science, University of Lausanne, Lausanne, Switzerland.

Julie Schanz (J)

Department of Clinical Chemistry and Interdisciplinary UMG Laboratory, University Medical Center Göttingen, Göttingen, Germany.

Matthias Bohn (M)

Clinical Pharmacy, Georg-August-University, Göttingen, Germany.

Martin Burtscher (M)

Faculty of Sports Science, University of Innsbruck, Innsbruck, Austria.

Andreas Fischer (A)

Department of Clinical Chemistry and Interdisciplinary UMG Laboratory, University Medical Center Göttingen, Göttingen, Germany.

Luise Poustka (L)

Department of Child and Adolescent Psychiatry & Psychotherapy, Center for Psychosocial Medicine, University Hospital Heidelberg, Heidelberg, Germany.

Peter Hammermann (P)

HBL Investmentpartners GmbH, München-Frankfurt, Germany.

Markus Stadler (M)

Datico Sport & Health GmbH, Burghausen, Germany.

Fred Lühder (F)

Institute for Neuroimmunology and Multiple Sclerosis Research, University Medical Center Göttingen, Göttingen, Germany.

Manvendra Singh (M)

Clinical Neuroscience, Max Planck Institute for Multidisciplinary Sciences, City Campus, Göttingen, Germany.

Klaus-Armin Nave (KA)

Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, City Campus, Göttingen, Germany.

Kamilla Woznica Miskowiak (KW)

Frederiksberg Hospital and Department of Psychology, Neurocognition and Emotion in Affective Disorders (NEAD) Centre, Copenhagen Affective Disorder Research Centre, Psychiatric Centre Copenhagen, University of Copenhagen, Copenhagen, Denmark.

Hannelore Ehrenreich (H)

Clinical Neuroscience, Max Planck Institute for Multidisciplinary Sciences, City Campus, Göttingen, Germany.
Georg-August-University, Göttingen, Germany.
Experimental Medicine, Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

Classifications MeSH